• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Do patients on biologic drugs for rheumatic disease need PCP prophylaxis?

作者信息

Tabanor Joy-Ann, Lakshminarayanan Santhanam

机构信息

Fellow, Division of Rheumatology, University of Connecticut School of Medicine, Farmington, CT, USA.

Chief, Division of Rheumatology, and Director, Rheumatology Fellowship Program, University of Connecticut School of Medicine, Farmington, CT, USA.

出版信息

Cleve Clin J Med. 2019 Jul;86(7):449-453. doi: 10.3949/ccjm.86a.18084.

DOI:10.3949/ccjm.86a.18084
PMID:31291178
Abstract
摘要

相似文献

1
Do patients on biologic drugs for rheumatic disease need PCP prophylaxis?
Cleve Clin J Med. 2019 Jul;86(7):449-453. doi: 10.3949/ccjm.86a.18084.
2
A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases.三苯甲砜-磺胺甲噁唑剂量递增方案可耐受用于风湿性疾病患者预防卡氏肺孢子虫肺炎。
Mod Rheumatol. 2013 Jul;23(4):752-8. doi: 10.1007/s10165-012-0730-x. Epub 2012 Aug 22.
3
Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?耶氏肺孢子菌肺炎的预防：对于未患艾滋病但接受大剂量慢性糖皮质激素治疗的肺部疾病患者而言，这有必要吗？
Expert Rev Respir Med. 2015 Apr;9(2):171-81. doi: 10.1586/17476348.2015.1002471.
4
Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.阿托伐醌、喷他脒和甲氧苄啶/磺胺甲恶唑对结缔组织病患者预防耶氏肺孢子菌肺炎的疗效。
J Infect Chemother. 2019 May;25(5):351-354. doi: 10.1016/j.jiac.2019.01.005. Epub 2019 Jan 31.
5
Infection Risk and Safety of Corticosteroid Use.使用皮质类固醇的感染风险与安全性
Rheum Dis Clin North Am. 2016 Feb;42(1):157-76, ix-x. doi: 10.1016/j.rdc.2015.08.004. Epub 2015 Oct 24.
6
Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.风湿性疾病中的耶氏肺孢子菌肺炎：一项为期20年的单中心经验
Clin Exp Rheumatol. 2017 Jul-Aug;35(4):671-673. Epub 2017 Jan 27.
7
Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia.磺胺甲恶唑-甲氧苄啶对间质性肺炎患者耶氏肺孢子菌肺炎的预防作用
Intern Med. 2008;47(1):15-20. doi: 10.2169/internalmedicine.47.0402. Epub 2008 Jan 1.
8
[Pneumocystis pneumonia among patients with systemic diseases].[全身性疾病患者中的肺孢子菌肺炎]
Presse Med. 2009 Feb;38(2):251-9. doi: 10.1016/j.lpm.2008.11.004. Epub 2008 Dec 4.
9
Rapid glucocorticoid tapering therapy to reduce mortality from pneumocystis pneumonia in patients with rheumatic disease.快速糖皮质激素减量疗法以降低风湿性疾病患者肺孢子菌肺炎的死亡率。
Mod Rheumatol. 2019 Jul;29(4):656-661. doi: 10.1080/14397595.2018.1496873. Epub 2018 Aug 13.
10
A survey of rheumatologists' practice for prescribing pneumocystis prophylaxis.一项关于风湿科医生开预防卡氏肺孢子虫肺炎处方的实践调查。
J Rheumatol. 2010 Apr;37(4):792-9. doi: 10.3899/jrheum.090843. Epub 2010 Mar 1.

引用本文的文献

1
Epidemiology, Risk Factors, and Prophylaxis Use for Pneumonia in the Non-HIV Population: A Retrospective Study in Québec, Canada.非艾滋病毒感染人群肺炎的流行病学、危险因素及预防措施使用情况：加拿大魁北克的一项回顾性研究
Open Forum Infect Dis. 2023 Dec 18;11(1):ofad639. doi: 10.1093/ofid/ofad639. eCollection 2024 Jan.
2
Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.并发症的并发症：一名系统性幼年特发性关节炎控制良好的患者复发性巨噬细胞活化综合征的诊断和治疗。
RMD Open. 2023 Jan;9(1). doi: 10.1136/rmdopen-2022-002611.
3
The Long-Acting Echinocandin, Rezafungin, Prevents Pneumocystis Pneumonia and Eliminates Pneumocystis from the Lungs in Prophylaxis and Murine Treatment Models.
长效棘白菌素瑞扎芬净在预防和小鼠治疗模型中可预防肺孢子菌肺炎并清除肺部的肺孢子菌。
J Fungi (Basel). 2021 Sep 11;7(9):747. doi: 10.3390/jof7090747.
4
Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators.将与生物制剂和靶向免疫调节剂相关的感染风险降至最低的预防策略。
Infect Drug Resist. 2020 Feb 18;13:513-532. doi: 10.2147/IDR.S233137. eCollection 2020.